Skip to Main Content

Author Details

James Logue
Center for Pathogen Research, University of Maryland School of Medicine
2017
48
21
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36299426Diet Induced Obesity and Diabetes Enhance Mortality and Reduces Vaccine Efficacy for SARS-CoV-2.bioRxiv2023
37850626SIRT-1 is required for release of enveloped enteroviruses.Elife2023
37846985Diet-induced obesity and diabetes enhance mortality and reduce vaccine efficacy for SARS-CoV-2.J Virol2023
37146076Target-agnostic drug prediction integrated with medical record analysis uncovers differential associations of statins with increased survival in COVID-19 patients.PLoS Comput Biol2023
37333151CNP blocks mitochondrial depolarization and inhibits SARS-CoV-2 replication <i>in vitro</i> and <i>in vivo</i>.bioRxiv2023
36854666Immunogenicity and protection of a variant nanoparticle vaccine that confers broad neutralization against SARS-CoV-2 variants.Nat Commun2023
36851550Development and Clinical Evaluation of a Rapid Point of Care Test for Ebola Virus Infection in Humans.Viruses2023
34626576Expanded Histopathology and Tropism of Ebola Virus in the Rhesus Macaque Model: Potential for Sexual Transmission, Altered Adrenomedullary Hormone Production, and Early Viral Replication in Liver.Am J Pathol2022
35441166Target-agnostic drug prediction integrated with medical record analysis uncovers differential associations of statins with increased survival in COVID-19 patients.medRxiv2022
35526532A SARS-CoV-2 Delta Variant Case Manifesting as Extensive Placental Infection and Fetal Transmission.Gynecol Obstet Invest2022
35962188PIKfyve-specific inhibitors restrict replication of multiple coronaviruses in vitro but not in a murine model of COVID-19.Commun Biol2022
36032397Self-assembling short immunostimulatory duplex RNAs with broad-spectrum antiviral activity.Mol Ther Nucleic Acids2022
36321826Mucosal and Systemic Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination Determined by Severity of Primary Infection.mSphere2022
35132414SARS-CoV-2 invades cognitive centers of the brain and induces Alzheimer's-like neuropathology.bioRxiv2022
32979434The immunoglobulins of cartilaginous fishes.Dev Comp Immunol2021
33646292Binding and Neutralization Antibody Titers After a Single Vaccine Dose in Health Care Workers Previously Infected With SARS-CoV-2.JAMA2021
33619473Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-Mâ¿¢ vaccination.Res Sq2021
33564763Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 in nonhuman primates following NVX-CoV2373 subunit vaccine with Matrix-Mâ¿¢ vaccination.bioRxiv2021
33532768Genetic and structural basis for recognition of SARS-CoV-2 spike protein by a two-antibody cocktail.bioRxiv2021
33778258Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine, and Pyronaridine: <i>In Vitro</i> Activity against SARS-CoV-2 and Potential Mechanisms.ACS Omega2021
34938283Rhesus Macaque CODEX Multiplexed Immunohistochemistry Panel for Studying Immune Responses During Ebola Infection.Front Immunol2021
34548634Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail.Nat Microbiol2021
34663813Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19.Nat Commun2021
34485950Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M vaccination.Cell Rep Med2021
34845453Self-assembling short immunostimulatory duplex RNAs with broad spectrum antiviral activity.bioRxiv2021
33941899A human-airway-on-a-chip for the rapid identification of candidate antiviral therapeutics and prophylactics.Nat Biomed Eng2021
33446655SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice.Nat Commun2021
32479821Filoviruses Infect Rhesus Macaque Synoviocytes in Vivo and Primary Human Synoviocytes in Vitro.Am J Pathol2020
31937163Post-exposure prophylactic vaccine candidates for the treatment of human Risk Group 4 pathogen infections.Expert Rev Vaccines2020
33060197Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.Science2020
33159858Single-Cell Profiling of Ebola Virus Disease In Vivo Reveals Viral and Host Dynamics.Cell2020
33184176The SKI complex is a broad-spectrum, host-directed antiviral drug target for coronaviruses, influenza, and filoviruses.Proc Natl Acad Sci U S A2020
33299990Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine and Pyronaridine: In vitro Activity Against SARS-CoV-2 and Potential Mechanisms.bioRxiv2020
32877576Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine.N Engl J Med2020
32674252Kikwit Ebola Virus Disease Progression in the Rhesus Monkey Animal Model.Viruses2020
32817221Broad Anti-coronavirus Activity of Food and Drug Administration-Approved Drugs against SARS-CoV-2 <i>In Vitro</i> and SARS-CoV <i>In Vivo</i>.J Virol2020
32275904Quantification of Viral and Host Biomarkers in the Liver of Rhesus Macaques: A Longitudinal Study of Zaire Ebolavirus Strain Kikwit (EBOV/Kik).Am J Pathol2020
32540901Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail.Science2020
30781518Ebola Virus Isolation Using Huh-7 Cells has Methodological Advantages and Similar Sensitivity to Isolation Using Other Cell Types and Suckling BALB/c Laboratory Mice.Viruses2019
31462952Acute transient tachypnea following gadoxetate administration in a rhesus macaque during contrast-enhanced magnetic resonance imaging.Radiol Case Rep2019
29253164Ebola Virus Neutralizing Antibodies Detectable in Survivors of theYambuku, Zaire Outbreak 40 Years after Infection.J Infect Dis2018
30107445Pan-Filovirus Serum Neutralizing Antibodies in a Subset of Congolese Ebolavirus Infection Survivors.J Infect Dis2018
30049622Persistence of Ebola virus after the end of widespread transmission in Liberia: an outbreak report.Lancet Infect Dis2018
29939303Identification of Combinations of Approved Drugs With Synergistic Activity Against Ebola Virus in Cell Cultures.J Infect Dis2018
29566079Testing therapeutics in cell-based assays: Factors that influence the apparent potency of drugs.PLoS One2018
29481881Use of the Filovirus Animal Non-Clinical Group (FANG) Ebola virus immuno-assay requires fewer study participants to power a study than the Alpha Diagnostic International assay.J Virol Methods2018
28003349Assessment and Optimization of the GeneXpert Diagnostic Platform for Detection of Ebola Virus RNA in Seminal Fluid.J Infect Dis2017
29020589Phase 2 Placebo-Controlled Trial of Two Vaccines to Prevent Ebola in Liberia.N Engl J Med2017
  • 1 - 48 of 48

Recommended Authors

Icahn School of Medicine at Mount Sinai New York
Career Start Year 2015
Number of shared co-authors 20
University of North Carolina at Chapel Hill
Career Start Year 2014
Number of shared co-authors 6
Yale School of Medicine
Career Start Year 2014
Number of shared co-authors 0
Texas Biomedical Research Institute
Career Start Year 2013
Number of shared co-authors 23
University of Texas Medical Branch
Career Start Year 2012
Number of shared co-authors 3
Yale School of Medicine
Career Start Year 2010
Number of shared co-authors 5
University of Texas Medical Branch
Career Start Year 2009
Number of shared co-authors 5
The Rockefeller University
Career Start Year 2008
Number of shared co-authors 3
University of Texas Medical Branch
Career Start Year 2008
Number of shared co-authors 11
University of Texas Medical Branch
Career Start Year 2008
Number of shared co-authors 7
Rutgers University
Career Start Year 2007
Number of shared co-authors 4
Centers for Disease Control and Prevention
Career Start Year 2006
Number of shared co-authors 0
Clinical Center (CC)
Career Start Year 2006
Number of shared co-authors 8
National Center for Toxicological Research
Career Start Year 2005
Number of shared co-authors 5
Institute for Human Infection and Immunity, University of Texas Medical Branch
Career Start Year 2005
Number of shared co-authors 4
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 2004
Number of shared co-authors 40
University of North Carolina at Chapel Hill
Career Start Year 2003
Number of shared co-authors 10
National Institute of Allergy and Infectious Disease, National Institute of Health
Career Start Year 2003
Number of shared co-authors 3
Centers for Disease Control and Prevention (CDC)
Career Start Year 2003
Number of shared co-authors 8
National Institutes of Allergy and Infectious Disease, National Institutes of Health
Career Start Year 2002
Number of shared co-authors 4
The Rockefeller University
Career Start Year 2002
Number of shared co-authors 3
Center for Infectious Diseases Research, Walter Reed Army Institute of Research
Career Start Year 2002
Number of shared co-authors 6
Texas Biomedical Research Institute
Career Start Year 2001
Number of shared co-authors 32
University of North Carolina School of Medicine
Career Start Year 1999
Number of shared co-authors 8
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1998
Number of shared co-authors 10
University of Texas Medical Branch
Career Start Year 1997
Number of shared co-authors 13
University College London
Career Start Year 1992
Number of shared co-authors 20
The University of Texas Medical Branch
Career Start Year 1991
Number of shared co-authors 3
University of Manitoba
Career Start Year 1991
Number of shared co-authors 7
Erasmus Medical Center
Career Start Year 1986
Number of shared co-authors 6

Collaborators

Center for Pathogen Research, University of Maryland School of Medicine
Co-authored papers 29
University of Maryland School of Medicine
Co-authored papers 15
Center for Pathogen Research, University of Maryland School of Medicine
Co-authored papers 7
Christchurch Hospital
Co-authored papers 4
Boston University
Co-authored papers 3
Vanderbilt University Medical Center
Co-authored papers 3
NYU Grossman School of Medicine
Co-authored papers 3
Vanderbilt University Medical Center
Co-authored papers 3
Wyss Institute for Biologically Inspired Engineering, Harvard University
Co-authored papers 3
Harvard Medical School
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Massachusetts Institute of Technology
Co-authored papers 3
Washington University School of Medicine
Co-authored papers 2
Co-authored papers 2
University of Texas Medical Branch
Co-authored papers 2
University of North Carolina
Co-authored papers 2
Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Icahn School of Medicine at Mount Sinai
Co-authored papers 2
University of Texas Medical Branch
Co-authored papers 2
University of North Carolina at Chapel Hill
Co-authored papers 2
National Institute of Biomedical Research (INRB)
Co-authored papers 2
Vanderbilt University Medical Center
Co-authored papers 2
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Co-authored papers 2
Stanford University School of Medicine
Co-authored papers 2
University of California San Francisco
Co-authored papers 1
University of California san francisco
Co-authored papers 1
University of California san francisco
Co-authored papers 1
University of Sheffield
Co-authored papers 1